Merkel cell carcinoma of unknown primary origin

Annals of Surgical Oncology

Volumn 19, Issue 7, 2012, Pages 2360-2366

  Deneve, Jeremiah L ^a   Messina, Jane L ^a,b   Marzban, Suroosh S ^a   Gonzalez, Ricardo J ^a,b   Walls, Brooke M ^a   Fisher, Kate J ^a   Chen, Y Ann ^a   Cruse, C Wayne ^a,b   Sondak, Vernon K ^a,b   Zager, Jonathan S ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; THYROID TRANSCRIPTION FACTOR 1;

ADJUVANT THERAPY; ADULT; AGED; AXILLA; CANCER DIAGNOSIS; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; CONSULTATION; EPITROCHLEAR LYMPH NODE; FEMALE; FOLLOW UP; HUMAN; INGUINAL REGION; INSTITUTIONAL REVIEW; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MERKEL CELL TUMOR; NECK DISSECTION; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; REVIEW; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MERKEL CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84862663273     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2213-2     Document Type: Review

References (34)

1. Hodgson NC. Merkel cell carcinoma: changing incidence trends. J Surg Oncol. 2005;89:1-4. (Pubitemid 40075960)
2. Pan D, Narayan D, Ariyan S. Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases. Plast Reconstr Surg. 2002;110:1259-65.
3. Koljonen V. Merkel cell carcinoma. World J Surg Oncol. 2006;4:7.
4. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127:2100-3. (Pubitemid 47258499)
5. Merkel cell carcinoma. In: Edge SB, editor. AJCC cancer staging manual. 7th ed. New York: Springer; 2010. p. 315-23.
6. Toker C. Trabecular carcinoma of the skin. Arch Dermatol. 1972;105:107-10.
7. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1, 024 cases. Ann Surg Oncol. 2001;8:204-8. (Pubitemid 32294799)
8. Veness MJ, Perera L, McCourt J, Shannon J, Hughes TM, Morgan GJ, et al. Merkel cell carcinoma: improved outcome with adjuvant radiotherapy. ANZ J Surg. 2005;75:275-81. (Pubitemid 40826890)
9. Tai PT, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol. 2000;18:2493-9. (Pubitemid 30415837)
10. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Peñas PF, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Der-matol. 2008;58:375-81. (Pubitemid 351226308)
11. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE, et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37:20-7.
12. Richetta AG, Mancini M, Torroni A, Lorè B, Iannetti G, Sardella B, et al. Total spontaneous regression of advanced Merkel cell carcinoma after biopsy: review and a new case. Dermatol Surg. 2008;34:815-22. (Pubitemid 351792299)
13. Val-Bernal JF, Garcia-Castano A, Garcia-Barredo R, Landeras R, De Juan A, Garijo MF, et al. Spontaneous complete regression in Merkel cell carcinoma after biopsy. Adv Anat Pathol. 2011;18: 174-7.
14. Muirhead R, Ritchie DM. Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. Clin Oncol (R Coll Radiol). 2007;19:96. (Pubitemid 46044067)
15. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008; 319:1096-100. (Pubitemid 351300792)
16. Mir R, Sciubba JJ, Bhuiya TA, Blomquist K, Zelig D, Friedman E. Merkel cell carcinoma arising in the oral mucosa. Oral Surg Oral Med Oral Pathol. 1988;65:71-5. (Pubitemid 18044280)
17. Snow SN, Larson PO, Hardy S, Bentz M, Madjar D, Landeck A, et al. Merkel cell carcinoma of the skin and mucosa: report of 12 cutaneous cases with 2 cases arising from the nasal mucosa. Dermatol Surg. 2001;27:165-70. (Pubitemid 32167926)
18. McCardle TW, Sondak VK, Zager J, Messina JL. Merkel cell carcinoma: pathologic findings and prognostic factors. Curr Probl Cancer. 2010;34:47-64.
19. Linjawi A, Jamison WB, Meterissian S. Merkel cell carcinoma: important aspects of diagnosis and management. Am Surg. 2001;67:943-7. (Pubitemid 33738122)
20. Iacocca MV, Abernethy JL, Stefanato CM, Allan AE, Bhawan J. Mixed Merkel cell carcinoma and squamous cell carcinoma of the skin. J Am Acad Dermatol. 1998;39:882-7. (Pubitemid 28520709)
21. Ordonez NG. Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol. 2000;7:123-7.
22. Hitchcock CL, Bland KI, Laney RG 3rd, Franzini D, Harris B, Copeland EM 3rd. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg. 1988;207:201-7. (Pubitemid 18063604)
23. Messina JL, Reintgen DS, Cruse CW, Rappaport DP, Berman C, Fenske NA, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997;4:389-95. (Pubitemid 127725513)
24. Allen PJ, Busam K, Hill AD, Stojadinovic A, Coit DG. Immu-nohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer. 2001;92:1650-5. (Pubitemid 32947851)
25. Veness M, Foote M, Gebski V, Poulsen M. The role of radiotherapy alone in patients with Merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys. 2010;78:703-9.
26. Rao NG. Review of the role of radiation therapy in the management of Merkel cell carcinoma. Curr Probl Cancer. 2010; 34:108-17.
27. Howle JR, Hughes TM, Gebski V, Veness MJ. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. J Am Acad Dermatol. Epub ahead of print 2011.
28. Gonzalez RJ, Padhya TA, Cherpelis BS, Prince MD, Aya-Ay ML, Sondak VK, et al. The surgical management of primary and metastatic Merkel cell carcinoma. Curr Probl Cancer. 2010; 34:77-96.
29. Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006;64:114-9. (Pubitemid 41831217)
30. Kudchadkar R, Deconti R. Systemic treatments for Merkel cell carcinoma. Curr Probl Cancer. 2010;34:97-107.
31. Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, et al. Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer. Epub ahead of print 2011.
32. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol. 2005;23:2300-9. (Pubitemid 46218722)
33. Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg. 2011;254:465-473.
34. Foote M, Veness M, Zarate D, Poulsen M. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease. J Am Acad Dermatol. Epub ahead of print 2011.